Pharming Group Nv logo

Pharming Group Nv Share Price (NASDAQ: PHAR)

$12.7

0.48

(3.93%)

Live

Last updated on

Check the interactive Pharming Group Nv Stock chart to analyse performance

Pharming Group Nv Key Stats

Check Pharming Group Nv key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$12.22
Open
$12.33
Market Capitalization
$861.9M
Today's Volume
$14.0K
Revenue TTM
$339.8M
EBITDA
$26.4M
Earnings Per Share (EPS)
$-0.14
Profit Margin
-2.41%
Quarterly Earnings Growth YOY
-0.61%
Return On Equity TTM
-3.7%

Stock Returns calculator for Pharming Group Nv Stock including INR - Dollar returns

The Pharming Group Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pharming Group Nv investment value today

Current value as on today

₹1,59,184

Returns

₹59,184

(+59.18%)

Returns from Pharming Group Nv Stock

₹55,257 (+55.26%)

Dollar Returns*

₹3,927 (+3.93%)

Indian investors sentiment towards Pharming Group Nv Stock

3%

Period: Jul 21, 2025 to Aug 20, 2025. Change in 30 Days versus previous period

Search interest for Pharming Group Nv Stock from India on INDmoney has increased by 3% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Pharming Group Nv

  • Name

    Holdings %

  • Silverberg Bernstein Capital Management LLC

    0.07%

Analyst Recommendation on Pharming Group Nv Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Pharming Group Nv(by analysts ranked 0 to 5 stars)

Pharming Group Nv Share Price Target

What analysts predicted

Upside of 141.47%

Target:

$30.67

Current:

$12.70

Pharming Group Nv share price target is $30.67, a slight Upside of 141.47% compared to current price of $12.70 as per analysts' prediction.

Pharming Group Nv Stock Insights

  • Price Movement

    In the last 7 days, PHAR stock has moved up by 8.3%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 79.09M → 94.37M (in $), with an average increase of 16.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -14.71M → 4.65M (in $), with an average increase of 416.0% per quarter
  • PHAR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 13.3%
  • PHAR vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.1% return, outperforming this stock by 105.4%
  • Price to Sales

    ForPHAR every $1 of sales, investors are willing to pay $2.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.1 for every $1 of sales.

Pharming Group Nv Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$297.2M
↑ 21.15%
Net Income
$-10.6M
↑ 0.91%
Net Profit Margin
-3.58%
↑ 0.72%

Pharming Group Nv Technicals Summary

Sell

Neutral

Buy

Pharming Group Nv is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Pharming Group Nv Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Pharming Group Nv logo
25.82%
37.77%
50.79%
10.53%
-26.17%
Regeneron Pharmaceuticals, Inc. logo
5.39%
-15.07%
-50.13%
-3.42%
-0.61%
Beone Medicines Ltd logo
4.61%
26.63%
56.19%
78.75%
30.26%
Vertex Pharmaceuticals Incorporated logo
-16.11%
-17.89%
-18.87%
34.22%
47.47%
Alnylam Pharmaceuticals, Inc. logo
40.82%
82.49%
64.08%
110.21%
247.67%

About Pharming Group Nv

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. It has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Organization
Pharming Group Nv
Employees
404
CEO
Mr. Fabrice Chouraqui Ph.D., Pharm.D.
Industry
Miscellaneous

Key Management of Pharming Group Nv

NameTitle
Dr. Sijmen de Vries M.B.A., M.D.
Strategic Advisor
Mr. Fabrice Chouraqui Ph.D., Pharm.D.
CEO & Executive Director
Ms. Mireille Sanders M.Sc.
Chief Operations Officer
Ms. Susanne Embleton
Investor Relations Manager
Mr. Ruud Van Outersterp
Chief Ethics & Compliance Officer
Mr. Michael Levitan
VP of Investor Relations & Corporate Communications
Ms. Ines Bernal
Chief People Officer
Dr. Anurag Relan M.D., MPH
Chief Medical Officer
Mr. Stephen Toor
Chief Commercial Officer & GM Americas
Dr. Alexander Breidenbach M.B.A.
Chief Business Officer

Important FAQs about investing in PHAR Stock from India :

What is Pharming Group Nv share price today?

Pharming Group Nv share price today is $12.70 as on . Pharming Group Nv share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Pharming Group Nv share?

Pharming Group Nv share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Pharming Group Nv stock price today i.e. is trending at $12.70, lower by 25.64% versus the 52 week high.

How to invest in Pharming Group Nv Stock (PHAR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pharming Group Nv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharming Group Nv Shares that will get you 0.1181 shares as per Pharming Group Nv share price of $12.70 per share as on August 21, 2025 at 11:39 PM IST.

What is the minimum amount required to buy Pharming Group Nv Stock (PHAR) from India?

Indian investors can start investing in Pharming Group Nv (PHAR) shares with as little as ₹87.2 or $1 (as of August 21, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹872.00 in Pharming Group Nv stock (as per the Rupee-Dollar exchange rate as on August 21, 2025). Based on Pharming Group Nv share’s latest price of $12.70 as on August 21, 2025 at 11:39 PM IST, you will get 0.7874 shares of Pharming Group Nv. Learn more about fractional shares .

What are the returns that Pharming Group Nv has given to Indian investors in the last 5 years?

Pharming Group Nv stock has given -26.17% share price returns and 17.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?